These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21505840)

  • 1. [Diabetic nephropathy].
    Menne J; Haller H
    Internist (Berl); 2011 May; 52(5):495-504. PubMed ID: 21505840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive therapy in diabetes mellitus].
    Hess B
    Ther Umsch; 1999 Jan; 56(1):25-32. PubMed ID: 10067131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.
    Jacobsen P; Rossing K; Parving HH
    Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating diabetic nephropathy with drug therapy.
    Martins D; Norris K
    Curr Diab Rep; 2001 Oct; 1(2):148-56. PubMed ID: 12643111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antihypertensive therapy in the treatment of diabetic nephropathy.
    Boner G; Cao Z; Cooper ME
    Diabetes Technol Ther; 2002; 4(3):313-21. PubMed ID: 12165170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of hypertension in kidney diseases].
    Ferrari P; Bonny O
    Praxis (Bern 1994); 2003 Dec; 92(50):2145-52. PubMed ID: 14708253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension in diabetic patients with nephropathy.
    Komers R; Anderson S
    Curr Diab Rep; 2001 Dec; 1(3):251-60. PubMed ID: 12643207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin receptor antagonists in patients with nephropathy due to type 2 diabetes.
    Eberhard R; Dikow R
    Ann Med; 2002; 34(7-8):507-13. PubMed ID: 12553490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for microalbuminuria and albuminuria in diabetes should be as important as checking blood pressure.
    Leoo T; Odar-Cederlöf I
    Blood Press; 2004; 13(6):326-9. PubMed ID: 15771215
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.
    Lewis JB; Berl T; Bain RP; Rohde RD; Lewis EJ
    Am J Kidney Dis; 1999 Nov; 34(5):809-17. PubMed ID: 10561135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R; Mogyorósi A; Ziyadeh FN
    Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.
    Jindal A; Garcia-Touza M; Jindal N; Whaley-Connell A; Sowers JR
    Endocrinol Metab Clin North Am; 2013 Dec; 42(4):789-808. PubMed ID: 24286950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of diabetic nephropathy].
    Stahl RA; Schoeppe W; Thaiss F
    Z Kardiol; 1993; 82 Suppl 4():45-8. PubMed ID: 8147061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is antihypertensive treatment the same for NIDDM and IDDM patients?
    Parving HH
    Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New therapeutic options in renal diseases--hypotensive therapy].
    Gaciong Z
    Pol Arch Med Wewn; 2004 Oct; 112 Spec No():57-63. PubMed ID: 15669202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should albuminuria be a therapeutic target in patients with hypertension and diabetes?
    de Zeeuw D
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):11S-15S; quiz A2-4. PubMed ID: 15539105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes.
    Lewis EJ
    Am J Hypertens; 2002 Oct; 15(10 Pt 2):123S-128S. PubMed ID: 12383593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How I treat... a hypertensive patient with diabetic nephropathy].
    Krzesinski JM
    Rev Med Liege; 1994 Aug; 49(8):427-8. PubMed ID: 7939009
    [No Abstract]   [Full Text] [Related]  

  • 20. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.